These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34083338)

  • 1. RELATE-a randomised controlled feasibility trial of a Relating Therapy module for distressing auditory verbal hallucinations: a study protocol.
    Lincoln TM; Pillny M; Schlier B; Hayward M
    BMJ Open; 2021 Jun; 11(6):e046390. PubMed ID: 34083338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smartphone-assisted guided self-help cognitive behavioral therapy for young people with distressing voices (SmartVoices): study protocol for a randomized controlled trial.
    Cavelti M; Kaeser JM; Lerch S; Bauer S; Moessner M; Berger T; Hayward M; Kaess M
    Trials; 2022 Oct; 23(1):902. PubMed ID: 36274185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing distress and improving social functioning in daily life in people with auditory verbal hallucinations: study protocol for the 'Temstem' randomised controlled trial.
    Jongeneel A; Scheffers D; Tromp N; Nuij C; Delespaul P; Riper H; van der Gaag M; van den Berg D
    BMJ Open; 2018 Mar; 8(3):e020537. PubMed ID: 29511020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trial.
    Garety P; Edwards CJ; Ward T; Emsley R; Huckvale M; McCrone P; Rus-Calafell M; Fornells-Ambrojo M; Gumley A; Haddock G; Bucci S; McLeod H; Hardy A; Peters E; Myin-Germeys I; Craig T
    Trials; 2021 May; 22(1):366. PubMed ID: 34034792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relating Therapy for distressing auditory hallucinations: A pilot randomized controlled trial.
    Hayward M; Jones AM; Bogen-Johnston L; Thomas N; Strauss C
    Schizophr Res; 2017 May; 183():137-142. PubMed ID: 27916286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing Unusual Sensory Experiences in People with First-Episode Psychosis (MUSE FEP): a study protocol for a single-blind parallel-group randomised controlled feasibility trial.
    Dudley R; Dodgson G; Common S; O'Grady L; Watson F; Gibbs C; Arnott B; Fernyhough C; Alderson-Day B; Ogundimu E; Kharatikoopaei E; Patton V; Aynsworth C
    BMJ Open; 2022 May; 12(5):e061827. PubMed ID: 35577470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial.
    Percie du Sert O; Potvin S; Lipp O; Dellazizzo L; Laurelli M; Breton R; Lalonde P; Phraxayavong K; O'Connor K; Pelletier JF; Boukhalfi T; Renaud P; Dumais A
    Schizophr Res; 2018 Jul; 197():176-181. PubMed ID: 29486956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of an Audio Visual Assisted Therapy Aid for Refractory auditory hallucinations (AVATAR therapy): study protocol for a randomised controlled trial.
    Craig TK; Rus-Calafell M; Ward T; Fornells-Ambrojo M; McCrone P; Emsley R; Garety P
    Trials; 2015 Aug; 16():349. PubMed ID: 26269098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stronger than your voices: A cognitive behavioral therapy for youth suffering from auditory verbal hallucinations.
    Maijer K; Staring T; Bartels-Velthuis AA; Palmen SJ; Sommer IE
    Clin Child Psychol Psychiatry; 2020 Apr; 25(2):386-400. PubMed ID: 31749371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional brain biomarkers of clinical response to rTMS of medication-resistant auditory hallucinations in schizophrenia patients: study protocol for a randomized sham-controlled double-blind clinical trial.
    Thomas F; Bouaziz N; Gallea C; Schenin-King Andrianisaina P; Durand F; Bolloré O; Benadhira R; Isaac C; Braha-Zeitoun S; Moulier V; Valero-Cabré A; Januel D
    Trials; 2019 Apr; 20(1):229. PubMed ID: 31014369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial.
    Craig TK; Rus-Calafell M; Ward T; Leff JP; Huckvale M; Howarth E; Emsley R; Garety PA
    Lancet Psychiatry; 2018 Jan; 5(1):31-40. PubMed ID: 29175276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smartphone-based ecological momentary assessment and intervention in a coping-focused intervention for hearing voices (SAVVy): study protocol for a pilot randomised controlled trial.
    Bell IH; Fielding-Smith SF; Hayward M; Rossell SL; Lim MH; Farhall J; Thomas N
    Trials; 2018 May; 19(1):262. PubMed ID: 29720208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CHALLENGE trial: the effects of a virtual reality-assisted exposure therapy for persistent auditory hallucinations versus supportive counselling in people with psychosis: study protocol for a randomised clinical trial.
    Smith LC; Mariegaard L; Vernal DL; Christensen AG; Albert N; Thomas N; Hjorthøj C; Glenthøj LB; Nordentoft M
    Trials; 2022 Sep; 23(1):773. PubMed ID: 36100943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating sleep problems in young people at ultra-high-risk of psychosis: study protocol for a single-blind parallel group randomised controlled feasibility trial (SleepWell).
    Waite F; Kabir T; Johns L; Mollison J; Tsiachristas A; Petit A; Černis E; Maughan D; Freeman D
    BMJ Open; 2020 Nov; 10(11):e045235. PubMed ID: 33172953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A psychological intervention for engaging dialogically with auditory hallucinations (Talking With Voices): A single-site, randomised controlled feasibility trial.
    Longden E; Corstens D; Bowe S; Pyle M; Emsley R; Peters S; Branitsky A; Chauhan N; Dehmahdi N; Jones W; Holden N; Larkin A; Miners A; Murphy E; Steele A; Morrison AP
    Schizophr Res; 2022 Dec; 250():172-179. PubMed ID: 36423442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biofeedback Enabled CALM (BeCALM)-the feasibility of biofeedback on procedural anxiety during radiation therapy: study protocol for a pilot randomised controlled trial.
    Forbes E; Clover K; Baker AL; McCarter KL; Oultram S; Kumar M; Wratten C; Tieu MT; Nixon J; Britton B
    BMJ Open; 2022 Dec; 12(12):e062467. PubMed ID: 36600369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT.
    Thomas SA; Drummond AE; Lincoln NB; Palmer RL; das Nair R; Latimer NR; Hackney GL; Mandefield L; Walters SJ; Hatton RD; Cooper CL; Chater TF; England TJ; Callaghan P; Coates E; Sutherland KE; Eshtan SJ; Topcu G
    Health Technol Assess; 2019 Sep; 23(47):1-176. PubMed ID: 31524133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between self-reported and clinician-rated evaluations of 1-year changes in auditory verbal hallucinations among schizophrenia patients.
    Kim SH; Hwang SS; Jung HY; Kim Y; Ahn YM; Chung IW; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109671. PubMed ID: 31220520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.